AU2021292703A1 - Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals - Google Patents

Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals Download PDF

Info

Publication number
AU2021292703A1
AU2021292703A1 AU2021292703A AU2021292703A AU2021292703A1 AU 2021292703 A1 AU2021292703 A1 AU 2021292703A1 AU 2021292703 A AU2021292703 A AU 2021292703A AU 2021292703 A AU2021292703 A AU 2021292703A AU 2021292703 A1 AU2021292703 A1 AU 2021292703A1
Authority
AU
Australia
Prior art keywords
hesperaloe
extract
saponin
disdehydroyuccaloiside
saponins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021292703A
Other languages
English (en)
Inventor
Thomas G. Shannon
Ning Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kimberly Clark Worldwide Inc
Original Assignee
Kimberly Clark Worldwide Inc
Kimberly Clark Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Worldwide Inc, Kimberly Clark Corp filed Critical Kimberly Clark Worldwide Inc
Publication of AU2021292703A1 publication Critical patent/AU2021292703A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2021292703A 2020-06-19 2021-06-21 Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals Pending AU2021292703A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063041224P 2020-06-19 2020-06-19
US63/041,224 2020-06-19
US202063124212P 2020-12-11 2020-12-11
US63/124,212 2020-12-11
PCT/US2021/038274 WO2021258056A1 (en) 2020-06-19 2021-06-21 Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals

Publications (1)

Publication Number Publication Date
AU2021292703A1 true AU2021292703A1 (en) 2023-02-09

Family

ID=79025349

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021292703A Pending AU2021292703A1 (en) 2020-06-19 2021-06-21 Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals

Country Status (8)

Country Link
EP (1) EP4168017A1 (es)
JP (1) JP2023530476A (es)
CN (1) CN115916216A (es)
AU (1) AU2021292703A1 (es)
BR (1) BR112022025821A2 (es)
CA (1) CA3182453A1 (es)
MX (1) MX2022016382A (es)
WO (1) WO2021258056A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115626948A (zh) * 2022-10-12 2023-01-20 吉林大学 一种新的螺甾皂苷单体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI223595B (en) * 1999-09-07 2004-11-11 Distributors Proc Inc Steroidal sapogenins for the control of coccidiosis in animals
ES2569907T3 (es) * 2008-06-27 2016-05-13 Zoetis Services Llc Composiciones adyuvantes novedosas
KR20110026669A (ko) * 2009-09-08 2011-03-16 김충정 콕시듐 예방 또는 치료용 조성물
CN106659787A (zh) * 2014-05-23 2017-05-10 辉宝动物保健公司 组合、组合物及向动物施用所述组合或组合物的方法
CN110464791A (zh) * 2019-09-04 2019-11-19 湖南宇山玉月农业科技有限公司 一种丝兰属植物在预防鸡坏死性肠炎的应用

Also Published As

Publication number Publication date
JP2023530476A (ja) 2023-07-18
BR112022025821A2 (pt) 2023-01-10
WO2021258056A1 (en) 2021-12-23
EP4168017A1 (en) 2023-04-26
CA3182453A1 (en) 2021-12-23
MX2022016382A (es) 2023-01-30
CN115916216A (zh) 2023-04-04

Similar Documents

Publication Publication Date Title
US20230302079A1 (en) Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
AU632067B2 (en) Matrix with immunomodulating activity
EP0362279B2 (en) Saponin adjuvant
Fleck et al. Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice
US20070059389A1 (en) Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters
US7407676B2 (en) Lignan extracts and compositions including the lignan extracts
EP4168017A1 (en) Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
Naveed et al. Enhancement in humoral response against inactivated Newcastle disease vaccine in broiler chickens administered orally with plant-derived soyasaponin
CN110087659B (zh) 将海参提取物作为有效成分的用于预防及治疗与布鲁赫膜功能降低相关疾病的组合物
JP5002097B2 (ja) コクシジウムによって引き起こされるヒトまたは動物の病気に対する予防治療剤及びコクシジウムの軽感染に対するヒトまたは動物の免疫のためのアジュバント剤
KR101109415B1 (ko) 가금류의 뉴캐슬병 바이러스에 대한 살바이러스 효능이 있는 가금용 사료첨가제 및 이를 함유한 사료조성물
Mohammed et al. Effect of Corianderum sativum on live weight gain, lipids, hematological and some blood parameters of Awassi female and male lambs
Orole et al. Activity of Ganoderma lucidum on Serum Marker Enzymes in Ochratoxin a treated albino rat models
Muliani et al. Test the Effectiveness of Bay Leaf Extract (Syzygium Polyanthum) in Lowering Uric Acid Levels in Male White Rats (Rattus Novergicus)
Rajeesh et al. Effect of vitamin E supplementation on serum alpha tocopherol and immune status of Murrah buffalo (Bubalus bubalis) calves
CN114848807A (zh) 一种蜂胶佐剂组合物、及其制备方法以及应用
Abdulla et al. Clinicopathological Studies on the Effect of Origanum majorana in Broilers
Virgínio Flávia Aparecida Nogueira, Lincoln Nunes Oliveira, Rayana Brito da Silva, Patrícia Silva Nery, Gercino Ferreira
Ukwah et al. Journal of Biological and Chemical Research
Giannenas et al. The inclusion of aromatic plants in chicken diets and their potential for the control of chicken coccidiosis